Skip to main content
. 2022 Aug 2;2(4):385–416. doi: 10.1515/mr-2022-0009

Figure 2:

Figure 2:

Genetic and imaging biomarkers. Imaging biomarkers can be cells and systems level: Phenotypic variations in molecular and cellular disease targets captured through molecular imaging like PET, and behavior related alterations in specific brain circuits measured by structural and functional MRI. PET, positron emission tomography; MRI, magnetic resonance imaging.